| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antitumor Activity and Tolerability of Gefitinib in Patients with Non–Small-Cell Lung Cancer Treated in an Expanded Access Program
|
Shah, Neelam T.
|
|
2003
|
5 |
Supplement 2 |
p. 182-186
5 p.
|
artikel
|
| 2 |
A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer
|
Leighl, Natasha B.
|
|
2003
|
5 |
Supplement 2 |
p. 107-112
6 p.
|
artikel
|
| 3 |
Chemotherapy for Malignant Pleural Mesothelioma
|
Jänne, Pasi A.
|
|
2003
|
5 |
Supplement 2 |
p. 98-106
9 p.
|
artikel
|
| 4 |
Combination Treatment with Weekly Docetaxel and Gemcitabine for Advanced Non–Small-Cell Lung Cancer in Elderly Patients and Patients with Poor Performance Status: Results of a Minnie Pearl Cancer Research Network Phase II Trial
|
Hainsworth, John D.
|
|
2003
|
5 |
Supplement 2 |
p. 33-38
6 p.
|
artikel
|
| 5 |
Cyclooxygenase-2 Inhibitors as Chemopreventive Agents in Lung Cancer
|
Price, Nancy
|
|
2004
|
5 |
Supplement 2 |
p. 333-336
4 p.
|
artikel
|
| 6 |
Cyclooxygenase-2 Inhibitors in Lung Cancer
|
Ramalingam, Sakkaraiappan
|
|
2004
|
5 |
Supplement 2 |
p. 245-253
9 p.
|
artikel
|
| 7 |
Epidermal Growth Factor Receptor Inhibitors, Gefitinib and Erlotinib (Tarceva™, OSI-774), in the Treatment of Bronchioloalveolar Carcinoma
|
DeGrendele, Heather
|
|
2003
|
5 |
Supplement 2 |
p. 83-85
3 p.
|
artikel
|
| 8 |
Genomic and Proteomic Analyses of Vascular Endothelial Growth Factor and Insulin-Like Growth Factor–Binding Protein 3 in Lung Adenocarcinomas
|
Gharib, Tarek G.
|
|
2004
|
5 |
Supplement 2 |
p. 307-312
6 p.
|
artikel
|
| 9 |
Granulocyte-Macrophage Colony-Stimulating Factor Gene–Transfected Autologous Tumor Cell Vaccine: Focus on Non–Small-Cell Lung Cancer
|
Nemunaitis, Jackie
|
|
2003
|
5 |
Supplement 2 |
p. 148-157
10 p.
|
artikel
|
| 10 |
Management of Advanced Non–Small-Cell Lung Cancer in Patients with a Performance Status of 2
|
Lilenbaum, Rogerio
|
|
2004
|
5 |
Supplement 2 |
p. 209-213
5 p.
|
artikel
|
| 11 |
Megavoltage Computed Tomography Imaging: A Potential Tool to Guide and Improve the Delivery of Thoracic Radiation Therapy
|
Welsh, James S.
|
|
2004
|
5 |
Supplement 2 |
p. 303-306
4 p.
|
artikel
|
| 12 |
Non–Small-Cell Lung Cancer in Elderly Patients: Influence of Age on Vinorelbine Oral Pharmacokinetics
|
Puozzo, Christian
|
|
2004
|
5 |
Supplement 2 |
p. 237-242
6 p.
|
artikel
|
| 13 |
Phase II Study of an Alternate Carboplatin and Gemcitabine Dosing Schedule in Advanced Non–Small-Cell Lung Cancer
|
Mott, Frank E.
|
|
2003
|
5 |
Supplement 2 |
p. 174-176
3 p.
|
artikel
|
| 14 |
Phase I Study of Weekly Alternating Therapy with Irinotecan/Cisplatin and Etoposide/Cisplatin for Patients with Small-Cell Lung Cancer
|
Johnson, Faye M.
|
|
2003
|
5 |
Supplement 2 |
p. 40-45
6 p.
|
artikel
|
| 15 |
Primary and Secondary Prevention of Non–Small-Cell Lung Cancer: The SPORE Trials of Lung Cancer Prevention
|
Khuri, Fadlo Raja
|
|
2003
|
5 |
Supplement 2 |
p. S36-S40
5 p.
|
artikel
|
| 16 |
Second-Line Chemotherapy for Non–Small-Cell Lung Cancer: Recent Data with Pemetrexed
|
Hanna, Nasser H.
|
|
2004
|
5 |
Supplement 2 |
p. S75-S79
5 p.
|
artikel
|
| 17 |
Trastuzumab plus Docetaxel in HER2/neu–Positive Non–Small-Cell Lung Cancer: A California Cancer Consortium Screening and Phase II Trial
|
Lara Jr, Primo N.
|
|
2004
|
5 |
Supplement 2 |
p. 231-236
6 p.
|
artikel
|
Tijdschrift beschrijving